P
PDS Biotechnology Corp D
D
PDSB
1.19500
USD
-0.01
(-0.42%)
مغلق
حجم التداول
6,898
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
54,623,450
الأخبار المقالات
العنوان: PDS Biotechnology Corp
القطاع: Healthcare
الصناعة: Biotechnology
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.